Complementary Vascular and Matrix Regulatory Pathways Underlie the Beneficial Mechanism of Action of Sorafenib in Liver Fibrosis

Hepatology - United States
doi 10.1002/hep.24427
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The Cellular Pathways of Liver Fibrosis in NASH

2019English

Pathways of Renal Fibrosis and Modulation of Matrix Turnover in Experimental Hypercholesterolemia

Hypertension
Internal Medicine
2005English

Sorafenib Prevents Liver Fibrosis in a Non-Alcoholic Steatohepatitis (NASH) Rodent Model

Brazilian Journal of Medical and Biological Research
ImmunologyCell BiologyPharmacologyBiochemistryBiophysicsNeuroscienceMedicineToxicologyPhysiologyPharmaceutics
2015English

Molecular Cues Guiding Matrix Stiffness in Liver Fibrosis

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2016English

Role of Regulatory T Cells in Murine Model of Liver Fibrosis Resolution

BMC Proceedings
BiochemistryMedicineGeneticsMolecular Biology
2012English

Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease

PLoS ONE
Multidisciplinary
2014English

Liver Fibrosis and Mechanisms of the Protective Action of Medicinal Plants Targeting Inflammation and the Immune Response

International Journal of Inflammation
AllergyImmunology
2015English

Liver Tumor Promoting Effect of Etofenprox in Rats and Its Possible Mechanism of Action

Journal of Toxicological Sciences
MedicineToxicology
2012English

Broad-Spectrum Matrix Metalloproteinase Inhibition Curbs Inflammation and Liver Injury but Aggravates Experimental Liver Fibrosis in Mice

PLoS ONE
Multidisciplinary
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy